Abstract:Systemic, non-viral siRNA delivery for cancer treatment is mainly achieved via condensation by cationic materials (e.g., lipids and cationic polymers), which nevertheless, suffers from poor serum stability, non-specific tissue interaction, and unsatisfactory membrane activity against efficient in vivo gene knockdown. Here, we report the design of a metastable, cancer-targeting siRNA delivery system based on two functional polymers, PVBLG-8, a cationic, helical cell-penetrating polypeptide, and poly(l-glutamic acid) (PLG), an anionic random-coiled polypeptide. PVBLG-8 with rigid, linear structure showed weak siRNA condensation capability, and PLG with flexible chains was incorporated as a stabilizer which provided sufficient molecular entanglement with PVBLG-8 to encapsulate the siRNA within the polymeric network. The obtained PVBLG-8/siRNA/PLG nanoparticles (PSP NPs) with positive charges were sequentially coated with additional amount of PLG, which reversed the surface charge from positive to negative to yield the metastable PVBLG-8/siRNA/PLG@PLG (PSPP) NPs. The PSPP NPs featured desired serum stability during circulation to enhance tumor accumulation via the enhanced permeability and retention (EPR) effect. Upon acidification in the tumor extracellular microenvironment and intracellular endosomes, the partial protonation of PLG on PSPP NPs surface would lead to dissociation of PLG coating from NPs, exposure of the highly membrane-active PVBLG-8, and surface charge reversal from negative to positive, which subsequently promoted tumor penetration, selective cancer cell internalization, and efficient endolysosomal escape. When siRNA against epidermal growth factor receptor (EGFR) was encapsulated, the PSPP NPs showed excellent tumor penetration capability, tumor cell uptake level, EGFR silencing efficiency, and tumor growth inhibition efficacy in U-87 MG glioblastoma tumor spheroids in vitro and in xenograft tumor-bearing mice in vivo, outperforming the PSP NPs and several commercial reagents such as Lipofectamine 2000 and poly(l-lysine) (PLL). This study therefore demonstrates a facile and unique design approach of metastable and charge reversal NPs, which overcomes multiple biological barriers against systemic siRNA delivery toward anti-cancer treatment.

Pegylated Carboxymethyl Chitosan/Calcium Phosphate Hybrid Anionic Nanoparticles Mediated Htert Sirna Delivery for Anticancer Therapy

Biocompatible and Colloidally Stabilized Mpeg-Pe/calcium Phosphate Hybrid Nanoparticles Loaded with Sirnas Targeting Tumors.

The Ph-Triggered Triblock Nanocarrier Enabled Highly Efficient Sirna Delivery for Cancer Therapy

Systemic Delivery of Sirna with Cationic Lipid Assisted PEG-PLA Nanoparticles for Cancer Therapy.

Bioreducible Cross-Linked Hyaluronic Acid/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor Therapy.

Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity

Targeted and Efficient Delivery of siRNA Using Tunable Polymeric Hybrid Micelles for Tumor Therapy.

Smart Nanoparticles Assembled by Endogenous Molecules for Sirna Delivery and Cancer Therapy Via CD44 and EGFR Dual-Targeting

Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of Sirna Cancer Therapeutics.

Systemic Delivery of Sirna by Hyaluronan-Functionalized Calcium Phosphate Nanoparticles for Tumor-Targeted Therapy

Systemic Sirna Delivery to a Spontaneous Pancreatic Tumor Model in Transgenic Mice by PEGylated Calcium Phosphate Hybrid Micelles.

Tumor Microenvironment-Response Calcium Phosphate Hybrid Nanoparticles Enhanced Sirnas Targeting Tumors in Vivo

Enhancing Sirna-Based Cancer Therapy Using a New Ph-Responsive Activatable Cell-Penetrating Peptide-Modified Liposomal System

A Mesoporous Silica Nanoparticle--pei--fusogenic Peptide System for Sirna Delivery in Cancer Therapy.

Ph-Responsive Complexes Using Prefunctionalized Polymers for Synchronous Delivery of Doxorubicin and Sirna to Cancer Cells

Treatment of Cervical Cancer by Sirna-Loaded Chitosan-Coated Calcium Phosphate Nanoparticles

Biodegradable Black Phosphorus Nanosheets Mediate Specific Delivery of Htert Sirna for Synergistic Cancer Therapy.

Stabilized Calcium Phosphate Hybrid Nanocomposite Using a Benzoxaborole-Containing Polymer for Ph-Responsive Sirna Delivery

Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles

Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor Treatment

Stimuli-responsive Hybrid Nanocarriers Developed by Controllable Integration of Hyperbranched PEI with Mesoporous Silica Nanoparticles for Sustained Intracellular Sirna Delivery.